Akèy › Maladi Crohn › Kansas › Topeka
Etid klinik pou Maladi Crohn nan Topeka, KS
6 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Topeka (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- Cotton O'Neil Digestive Health Center ( Site 5033), Topeka
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Cotton-O'Neil Clinical Research Center, Topeka
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- University of Kansas Health System Saint Francis Campus, Topeka
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Ap rekriteFaz 2
- Cotton O'Neil Digestive Health Center, Topeka
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Ap rekriteFaz 2
- Cotton O'Neil Digestive Health Center, Topeka
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Ap rekriteFaz 4
- Cotton ONeil Clinical Research Center, Topeka
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Boston, MA19 etid
- Miami, FL19 etid
- Orlando, FL17 etid
- Houston, TX17 etid
- Atlanta, GA17 etid
- Tyler, TX16 etid
- San Diego, CA15 etid
- San Antonio, TX15 etid
- Los Angeles, CA15 etid
Lòt etid nan Topeka
- Maladi fwa steatotik7 etid
- Kansè pwostat7 etid
- Sipwa7 etid
- Kansè Poumon ki pa ti selil7 etid
- Obèsite6 etid
- Kansè nan tete6 etid
- Kansè poumon6 etid
- Maladi kadyovaskilè5 etid
- Dyabèt Tip 25 etid
- Kansè vejik4 etid
- Kansè Ezofajyen4 etid
- Melanom4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.